Ganga Pharmaceuticals Ltd
Incorporated in 1989, Ganga Pharmaceuticals Ltd is in the business of manufacturing & trading in Ayurvedic pharmaceuticals & allied products[1]
- Market Cap ₹ 7.25 Cr.
- Current Price ₹ 15.0
- High / Low ₹ 28.5 / 13.1
- Stock P/E 362
- Book Value ₹ 13.2
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Stock is trading at 1.13 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Promoter holding has decreased over last 3 years: -10.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | |
|---|---|---|
| 3.08 | 2.37 | |
| 2.70 | 2.34 | |
| Operating Profit | 0.38 | 0.03 |
| OPM % | 12.34% | 1.27% |
| 0.17 | 0.25 | |
| Interest | 0.24 | 0.19 |
| Depreciation | 0.05 | 0.05 |
| Profit before tax | 0.26 | 0.04 |
| Tax % | 23.08% | 50.00% |
| 0.19 | 0.02 | |
| EPS in Rs | 0.47 | 0.05 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -89% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 44% |
| 1 Year: | 26% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | |
|---|---|---|
| Equity Capital | ||
| Reserves | ||
| Total Liabilities | ||
| CWIP | ||
| Investments | ||
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | |
|---|---|---|
| -0.31 | -0.18 | |
| 0.37 | 0.28 | |
| -0.29 | -0.10 | |
| Net Cash Flow | -0.22 | 0.00 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | |
|---|---|---|
| Debtor Days | ||
| Inventory Days | ||
| Days Payable | ||
| Cash Conversion Cycle | ||
| Working Capital Days | ||
| ROCE % |
Documents
Announcements
-
Statement Of Deviation For September 30, 2024
8 Nov - Statement of no deviation in fund utilization.
-
Board Meeting Outcome for For The Meeting Held On Friday, November 08, 2024
8 Nov - Board approved un-audited financial results for H1 2024.
-
Un-Audited Financial Results Of The Company For The Half
Year Ended On September 30, 2024.
8 Nov - Board approved un-audited financial results for H1 2024.
-
Board Meeting Intimation For Consider And Approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2024
6 Nov - Board meeting to approve unaudited financial results.
-
Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2024
5 Nov - Board meeting to approve unaudited financial results.
Annual reports
Concalls
-
May 2024TranscriptNotesPPT
Business Overview:[1][2]
Company does production of Ayurvedic Medicines by using techniques strictly as per Ancient text and Ayurved pharma companies. Apart from manufacturing, it is also into marketing and distribution of Bulk Ayurvedic Medicines in Mumbai